本頁面由Tiger Trade Technology Pte. Ltd.提供服務

BridgeBio Pharma, Inc.

72.44
-0.0600-0.08%
盤後72.440.00000.00%19:57 EDT
成交量:176.66萬
成交額:1.28億
市值:141.84億
市盈率:-20.30
高:74.11
開:73.23
低:71.98
收:72.50
52周最高:93.42
52周最低:48.78
股本:1.96億
流通股本:1.67億
量比:0.87
換手率:1.06%
股息:- -
股息率:- -
每股收益(TTM):-3.5686
每股收益(LYR):-3.7850
淨資產收益率:-1789.67%
總資產收益率:-26.00%
市淨率:-5.64
市盈率(LYR):-19.14

資料載入中...

2019/06/27

持股變動聲明

Initial statement of beneficial ownership of securities
2019/06/27

持股變動聲明

Initial statement of beneficial ownership of securities
2019/06/27

持股變動聲明

Initial statement of beneficial ownership of securities
2019/06/27

持股變動聲明

Initial statement of beneficial ownership of securities
2019/06/27

持股變動聲明

Initial statement of beneficial ownership of securities
2019/06/27

持股變動聲明

Initial statement of beneficial ownership of securities
2019/06/27

持股變動聲明

Initial statement of beneficial ownership of securities
2019/06/27

持股變動聲明

Initial statement of beneficial ownership of securities
2019/06/26

[修訂]招股説明書

[Amend] General form for registration of securities under the Securities Act of 1933
2019/06/25

SEC問詢函

[Cover]Correspondence
2019/06/24

SEC問詢函

[Cover]Correspondence
2019/06/24

[修訂]招股説明書

[Amend] General form for registration of securities under the Securities Act of 1933
2019/06/17

[修訂]招股説明書

[Amend] General form for registration of securities under the Securities Act of 1933
2019/06/11

[修訂]招股説明書

[Amend] General form for registration of securities under the Securities Act of 1933
2019/05/30

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/05/29

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/05/24

招股説明書

General form for registration of securities under the Securities Act of 1933
2018/12/13

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2018/12/12

持股變動聲明

Statement of changes in beneficial ownership of securities
2018/12/11

超過5%披露

[Amend] General statement of acquisition of beneficial ownership